Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human UDP-glucuronosyltransferase 2B7.

A Radominska-Pandya1, J M Little, P J Czernik

  • 1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock 72205, USA. RadominskaAnna@uams.edu

Current Drug Metabolism
|August 22, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular Amputees: A Study in Disappointment.

Journal of bioethical inquiry·2022
Same author

Electron Cooling in a Magnetically Expanding Plasma.

Physical review letters·2016
Same author

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption.

EBioMedicine·2016
Same author

High bone mass in adult mice with diet-induced obesity results from a combination of initial increase in bone mass followed by attenuation in bone formation; implications for high bone mass and decreased bone quality in obesity.

Molecular and cellular endocrinology·2015
Same author

Nanodelivery of Parthenolide Using Functionalized Nanographene Enhances its Anticancer Activity.

RSC advances·2015
Same author

Estimating ON and OFF contributions to the photopic hill: normative data and clinical applications.

Documenta ophthalmologica. Advances in ophthalmology·2014
Same journal

Branched-Chain Amino Acids (BCAAs): Metabolism and Their Roles In Inflammation Regulation and Disease.

Current drug metabolism·2026
Same journal

Corrigendum to: Nanocochleates in Clinical Trials: A Review of Current Status, Challenges, and Future Directions.

Current drug metabolism·2026
Same journal

Shenfu Decoction Extends Survival Time of Seawater-Induced Hypothermia in Rats: The Role of Metabolomics and Gut Microbiota.

Current drug metabolism·2026
Same journal

Nucleic Acid Nanomaterials Targeting Autophagy in Bone Regeneration.

Current drug metabolism·2026
Same journal

Nicotinamide N-Methyltransferase (NNMT): A Central Regulator in Hepatocellular Carcinoma Metabolism and Therapeutic Targeting - A Systematic Review.

Current drug metabolism·2026
Same journal

Chlorzoxazone-based One-Sample Method for Estimating In Vivo CYP2E1 Activity in Mice.

Current drug metabolism·2026
See all related articles

UDP-Glucuronosyltransferases (UGTs) are enzymes that aid in detoxification and excretion. This review focuses on UGT2B7, a major human isoform, detailing its expression, localization, and gene characteristics.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • UDP-Glucuronosyltransferases (UGTs) are key enzymes in drug metabolism, facilitating detoxification by converting lipophilic compounds into hydrophilic derivatives for excretion.
  • While primarily involved in detoxification, glucuronidation can also produce biologically active or toxic metabolites.
  • UGTs are implicated in regulating nuclear receptor ligand concentrations, influencing cellular signaling pathways.

Purpose of the Study:

  • To review the identification, expression, and localization of the UGT2B7 isoform in human tissues.
  • To explore the substrate specificity and gene promoter characteristics of UGT2B7.
  • To consolidate current knowledge on UGT2B7's role in drug metabolism and its extrahepatic and nuclear localization.

Main Methods:

Related Experiment Videos

  • Literature review of published studies and investigator data on UGT2B7.
  • Analysis of existing information regarding UGT2B7 expression patterns in various human tissues.
  • Examination of data on UGT2B7 substrate specificity, localization (including nuclear and extrahepatic), and gene structure.

Main Results:

  • UGT2B7 is a significant human UGT2B subfamily isoform involved in metabolizing diverse endogenous compounds and xenobiotics.
  • The review covers the history of UGT2B7 identification and its expression across human tissues.
  • Information on UGT2B7's substrate range, extrahepatic and nuclear localization, and gene/promoter characteristics is compiled.

Conclusions:

  • UGT2B7 plays a crucial role in the glucuronidation of numerous substrates, impacting drug metabolism and detoxification.
  • Understanding UGT2B7's specific functions, localization, and genetic regulation is vital for predicting drug efficacy and toxicity.
  • This review provides a comprehensive overview of UGT2B7, highlighting its importance in human health and disease.